Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto – Presentation of Half-Year Report 2023

By HC Andersen Capital
BioPorto

Meet and ask questions to BioPorto CEO Tony Pare and CFO Neil Goldman on Tuesday 1 August at 2.00 PM CEST when they present the financial results for the first six months of 2023 along with the latest development for the NGAL Test and the outcome of the rights issue successfully completed in June 2023.

Disclaimer: HC Andersen Capital receives payment from Bioporto for a Digital IR/Corporate Visibility subscription agreement. /ANALYST Claus Thestrup 15:15 PM 5 July 2023.

Recent videos

Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
2025-12-09 22:11 Herantis Pharma
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-09 22:10 Aiforia Technologies
Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-09 22:10 Orion
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
2025-12-09 22:09 Aiforia Technologies
Life Science Night | December 9, 2025
2025-12-09 14:30 Orion
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.